MedTrace Logo

CAPERE Thrombectomy System Post-Market Clinical Follow Up Study

NCT03869645 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2022-09-13

No results posted yet for this study

Summary

A prospective, single-arm, non-blinded study, intending to collect and evaluate data in up to forty (40) human subjects with acute thrombosis, treated with the CAPERE™ Thrombectomy System.

Conditions

  • Observational Study

Interventions

DEVICE

CAPERE Thrombectomy System

Mechanical thrombectomy of acute thrombus in peripheral vasculature with the CAPERE Thrombectomy System

Sponsors & Collaborators

  • Medtronic Endovascular

    lead INDUSTRY

Principal Investigators

  • Tiffany Wu, MD · Unity Health Toronto

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-08-26
Completion
2020-08-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03869645 on ClinicalTrials.gov